SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-23-047083 from Aquaron Acquisition Corp. (AQUNR)

Aquaron Acquisition Corp.
Date: June 7, 2023 · CIK: 0001861063 · Accession: 0001213900-23-047083

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-41470

Referenced dates: June 5, 2023

Date
June 7, 2023
Author
/s/ Yi Zhou
Form
CORRESP
Company
Aquaron Acquisition Corp.

Letter

Via Edgar Division of Corporation Finance Office of Real Estate & Construction Re: Aquaron Acquisition Corp. Preliminary Proxy Statement on Schedule 14A Filed May 30, 2023 File No. 001-41470

Dear Mr. Gabor:

This letter is in response to the letter dated June 5, 2023, from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) addressed to Aquaron Acquisition Corp. (the “Company,” “we,” and “our”). For ease of reference, we have recited the Commission’s comments in this response and numbered them accordingly. The amendment to the Preliminary Proxy Statement on Schedule 14A (the “Preliminary Schedule 14A”) is being filed to accompany this letter.

Preliminary Proxy Statement on Schedule 14A filed May 30, 2023

General

1. With a view toward disclosure, please tell us whether either of your sponsors is, is controlled by, or has substantial ties with a non-U.S. person. If so, also include risk factor disclosure that addresses how this fact could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination with a U.S. target company should the transaction be subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential targets with which you could complete an initial business combination may be limited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants, which would expire worthless.

Response: In response to the Staff’s comments, we added the required disclosures under “Background — U.S. Foreign Investment Regulations” on page 18 of the Preliminary Schedule 14A accordingly.

We appreciate the assistance the Staff has provided with its comments. If you have any questions, please do not hesitate to call our counsel, Sally Yin, Esq., of Wilson Sonsini Goodrich & Rosati, at (212) 497-7747.

Very truly yours,
By:
/s/ Yi Zhou

Show Raw Text
CORRESP
1
filename1.htm

Aquaron Acquisition Corp.

515 Madison Avenue, 8th Floor

New York, NY 10022

June 7, 2023

Via Edgar

Jeffrey Gabor

Division of Corporation Finance

Office of Real Estate & Construction

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

    Re:
    Aquaron Acquisition Corp.

    Preliminary Proxy Statement on Schedule 14A

Filed May 30, 2023

    File No. 001-41470

Dear Mr. Gabor:

This letter is in response to the letter dated
June 5, 2023, from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) addressed
to Aquaron Acquisition Corp. (the “Company,” “we,” and “our”). For ease of reference, we have recited
the Commission’s comments in this response and numbered them accordingly. The amendment to the Preliminary Proxy Statement on Schedule
14A (the “Preliminary Schedule 14A”) is being filed to accompany this letter.

Preliminary Proxy Statement on Schedule 14A
filed May 30, 2023

General

1. With a view toward disclosure, please tell
us whether either of your sponsors is, is controlled by, or has substantial ties with a non-U.S. person. If so, also include risk factor
disclosure that addresses how this fact could impact your ability to complete your initial business combination. For instance, discuss
the risk to investors that you may not be able to complete an initial business combination with a U.S. target company should the transaction
be subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately
prohibited. Disclose that as a result, the pool of potential targets with which you could complete an initial business combination may
be limited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction
could prevent you from completing an initial business combination and require you to liquidate. Disclose the consequences of liquidation
to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and
the warrants, which would expire worthless.

Response: In response to the
Staff’s comments, we added the required disclosures under “Background — U.S. Foreign Investment
Regulations” on page 18 of the Preliminary Schedule 14A accordingly.

We appreciate the assistance the Staff has provided
with its comments. If you have any questions, please do not hesitate to call our counsel, Sally Yin, Esq., of Wilson Sonsini Goodrich
& Rosati, at (212) 497-7747.

Very truly yours,

    By:
    /s/ Yi Zhou

    Yi Zhou

    Chief Executive Officer

Sally Yin, Esq.

Wilson Sonsini Goodrich & Rosati